Mauritania currently reports an pregnant women living with hiv antiretroviral therapy coverage for pmtct of 23%, which represents an increase of 16% (228.6%) from 2021.
Pregnant women living with HIV antiretroviral therapy coverage for PMTCT in Mauritania
No matching regions
Source:
Data availability:
Regions:
215
Date range: 2000 to 2022
Points:
13,975
Measure:
%
More indicators for Mauritania
Male unintentional poisoning
0.7
-0.0
(2021)
Female wasting in children
10.7%
+2.3%
(2022)
Female prevalence of HIV
0.1%
0%
(2022)
Out-of-pocket expenditure PPP per capita
intl dollar112
+intl dollar11
(2022)
Birth registration
44.8%
-20.8%
(2021)
Contraceptive modern method prevalence
12.8%
-2.8%
(2021)
Mauritania PMTCT antiretroviral therapy coverage between 2000 and 2022
| Period | Value | Change |
|---|---|---|
| 2022 | 23% | +16% |
| 2021 | 7% | -13% |
| 2020 | 20% | -15% |
| 2019 | 35% | +16% |
| 2018 | 19% | +7% |
| 2017 | 12% | -5% |
| 2016 | 17% | -37% |
| 2015 | 54% | -4% |
| 2014 | 58% | +49% |
| 2013 | 9% | +5% |
| 2012 | 4% | -5% |
| 2011 | 9% | +1% |
| 2010 | 8% | 0% |
| 2009 | 8% | +3% |
| 2008 | 5% | -2% |
| 2007 | 7% | +6% |
| 2006 | 1% | +1% |
| 2005 | 0% | 0% |
| 2004 | 0% | 0% |
| 2003 | 0% | 0% |
| 2002 | 0% | 0% |
| 2001 | 0% | 0% |
| 2000 | 0% |